Eurotranspharma

Name

Eurotranspharma

Legal name

EUROTRANSPHARMA HOLDING B.V.

Website

https://eurotranspharma.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Logistics Services

NAICS

Couriers and Express Delivery Services (4921), Local Messengers and Local Delivery (49221), Couriers and Messengers (492)

SIC

Transportation Services (4700), Services-Health Services (8000)

akta.pro primary industry

Pharma & Life Sciences Cold Chain Transport (GDP) (TLADAHAI)

akta.pro secondary industries

Pharmaceutical Cold-Chain Delivery (2–8°C / CRT) (TLAAAJAC), Healthcare & Medical STAT Courier (Specimens, Blood, Pharma) (TLAAADAE), Medical Specimens & Diagnostics Cold Delivery (TLAAAJAF)

Keywords

• Pharmaceutical logistics
• Temperature-controlled transport
• GDP-compliant distribution
• Cold chain delivery
• Healthcare freight forwarding

Headquarters

HQ city

Saint-laurent-blangy

HQ country

France

HQ region

Europe

Offices39 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. GDP-Compliant Last Mile Distribution Services: Core B2B logistics services providing temperature-controlled pharmaceutical distribution to hospitals, pharmacies, wholesalers, laboratories, and directly to patients across Europe. Services include domestic and international last mile distribution, urgent pharma transport, and specialized direct-to-patient delivery.
2. Freight Forwarding Services: International freight forwarding services for pharmaceutical products through partnership with Transpharma International and Skandi Network partners.
3. Specialized Healthcare Logistics Services: Extra mile services including delivery surveys, inventory counting, custom solutions for healthcare supply chain optimization.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Eurotranspharma provides GDP-compliant, temperature-controlled last-mile distribution of pharmaceutical and healthcare products across Europe. Its services span domestic and international last-mile delivery, urgent pharma transport, direct-to-patient delivery, and value-added extra mile services, executed via a proprietary fleet of more than 1,600 validated vehicles and a network of 54 hubs and agencies in 8 countries, extended through the Skandi Network partnership to 26 countries.

Product overview

Eurotranspharma operates as a unified product portfolio under the Walden Group (now part of Yusen Logistics Healthcare) offering GDP-certified temperature-controlled pharmaceutical last-mile logistics across Europe. The core offering centers on Healthcare Transport Services comprising domestic and international last-mile distribution, urgent transport, direct-to-patient delivery, and extra mile services, all supported by proprietary technology platforms including the Control Tower System for real-time temperature and location monitoring, a Track & Trace customer portal, and a specialized TMS for healthcare logistics. The network spans 8 countries directly with 15 hubs and 42 agencies, reaching 26 countries through the Skandi Network partnership, processing over 15 million shipments annually with a fleet of over 1,600 validated vehicles.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Transport Services Core B2B offering for pharmaceutical manufacturers, biotech firms, medical device makers, and diagnostics companies providing temperature-controlled last-mile delivery across Europe.
• Domestic Distribution of Medicines Temperature-controlled national last-mile delivery of pharmaceuticals and healthcare products within individual European countries, complying with GDP standards.
• International Last Mile Distribution Cross-border pharmaceutical distribution from European distribution centers to recipients in other countries, maintaining GDP-compliant temperature control throughout.
• Urgent Pharma Transport Express delivery for urgent pharmaceutical shipments, including same-day pickup and delivery where distance permits, and next-day (D+1) delivery as standard.
• Direct to Patient (DtP) Delivery Specialized delivery of medicines and healthcare products directly to patients' homes or chosen locations, enabled by consignee certification processes using unique QR codes to ensure patient safety.
• Extra Mile Services Value-added services including delivery surveys at healthcare professional sites, customized adaptation to delivery conditions, assistance with unpacking and pallet returns, inventory counting, and consulting for supply chain optimization.
• Consignee Certification Hypercare process guaranteeing certified delivery to the correct recipient by appointment, using unique QR codes for verification in direct-to-patient deliveries.
• Track & Trace Extranet Customer-facing web portal providing real-time shipment tracking and visibility across the distribution network for Benelux, France, Spain, and Germany.
• GDP-Certified Network Europe-wide network of 15 hubs, 42 agencies, and over 1,600 temperature-controlled vehicles certified in Good Distribution Practices, operating in 8 countries with coverage in 26 countries via the Skandi Network partnership.

Quantifiable outcome

• 82,000 shipments delivered daily across Europe
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

• Yusen Logistics EuropeflagshipStrategic or Co-development Partner · 22 December 2025Yusen Logistics Europe acquired Eurotranspharma along with other Walden Group subsidiaries (Movianto, Transpharma International, Walden Digital) in December 2025 to establish a dedicated healthcare logistics platform. The acquisition supports Yusen Logistics' new mid-term plan launching April 2026 and strengthens their position in European healthcare logistics sector.
• Skandi NetworkcoreChannel Partner/ Reseller/ DistributorEurotranspharma is a founding member of Skandi Network, a GDP-compliant pharmaceutical transport association with over 4,500 vehicles across 26 European countries. The partnership enables coverage exceeding 14 million shipments annually and extends Eurotranspharma's reach beyond its 9 directly served countries.
• Transpharma InternationalcoreStrategic or Co-development PartnerSister company within Walden Group providing international freight forwarding services. Partnership enables urgent express delivery services and cross-border pharmaceutical transport solutions, particularly in Belgium and throughout Europe.
• Walden GroupflagshipStrategic or Co-development PartnerParent company until December 2025 acquisition by Yusen Logistics. Walden Group is a family-owned company with 6 operating divisions specializing in healthcare logistics and express transport, founded in 1951 in Auvergne, France. Generated 1.9 billion euros revenue in 2021 with over 6,000 employees across 12 countries.
• Walden GroupflagshipStrategic or Co-development PartnerEurotranspharma is part of the global Yusen Logistics Healthcare network (formerly Walden Group healthcare division) providing safe, regulation-compliant, and timely deliveries of medicines and healthcare products to hospitals, pharmacies, wholesalers, and healthcare facilities across Europe.
• MoviantocoreStrategic or Co-development PartnerSister company within Walden Group (now part of Yusen Logistics Healthcare) providing pharmaceutical supply chain management and warehousing services.
• CiblexminorChannel Partner/ Reseller/ DistributorExpress delivery company within Walden Group network, sharing data systems and potentially providing complementary delivery services.
• Relais ColisminorChannel Partner/ Reseller/ DistributorParcel delivery network within Walden Group, sharing data systems and potentially providing complementary delivery services.
• Transpharma International (Belgium Operations)coreChannel Partner/ Reseller/ DistributorPartnership for express delivery services in Belgium offering same-day and within-hours delivery options, working together to provide express pharmaceutical delivery services across Europe.

Scale indicators13 records

Recent moves4 records

Expansion highlights6 records

Broad incumbents

• FedEx Custom Critical / FedEx Healthcare: FedEx Custom Critical (formerly FedEx Custom Critical) and the broader FedEx Healthcare Solutions provide time-sensitive and temperature-controlled pharmaceutical transport. Comparable to Eurotranspharma in urgent pharma transport and cold-chain capabilities, with global air and ground networks.
• Geodis (Healthcare & Life Sciences): Geodis runs a Healthcare & Life Sciences vertical offering GDP-compliant road, air, and sea freight plus contract logistics across Europe. Comparable to Eurotranspharma in European pharma logistics, with broader multimodal and global footprint.
• DHL Supply Chain (Life Sciences & Healthcare): DHL Supply Chain operates one of the largest dedicated Life Sciences & Healthcare verticals globally, providing GDP-compliant temperature-controlled warehousing and transport. Directly comparable to Eurotranspharma in pharmaceutical distribution, but with global scale and broader service portfolio.
• Kuehne+Nagel (KN PharmaChain / Life Sciences & Healthcare): Kuehne+Nagel runs KN PharmaChain, a global GDP-compliant pharma and healthcare logistics platform covering air, sea, road, and contract logistics. Overlaps directly with Eurotranspharma's pharmaceutical last-mile offering while operating at significantly larger global scale.
• UPS Healthcare (marken / MNX / Polar Speed): UPS Healthcare consolidates marken, Polar Speed, and MNX into a global cold-chain pharma logistics network offering time-critical and temperature-controlled transport. Direct comparison to Eurotranspharma in GDP-compliant pharma last-mile, with broader global reach.
• DSV (Life Sciences / Pharma & Healthcare): DSV operates dedicated Pharma & Healthcare and Life Sciences divisions providing GDP-compliant air, sea, and road transport, with strong European road freight presence. Comparable to Eurotranspharma in European pharma road transport while offering broader global forwarding.

Direct peers

• Movianto: Movianto is Eurotranspharma's former sister company (now also under Yusen Logistics Healthcare), specializing in pharmaceutical warehousing, distribution, and supply chain solutions across Europe. Highly comparable in target customers, GDP compliance, and therapeutic logistics, with complementary warehousing depth.
• Transpharma International: Transpharma International is Eurotranspharma's former Walden Group sister entity, now under Yusen Logistics Healthcare, providing international freight forwarding and urgent express pharma transport in Belgium and across Europe. Closely aligned in customer base, GDP standards, and pharmaceutical transportation focus.
• Cencora (formerly AmerisourceBergen) / World Courier: World Courier (Cencora's specialty courier) provides global GDP-compliant pharmaceutical and clinical trial transport with cold-chain capabilities. Direct comparison to Eurotranspharma in pharma cold-chain last-mile, especially for clinical trials and specialty pharma, with deeper clinical trial specialization.

Regional players

• SF Healthcare (SF International / Cold Chain): SF International Healthcare and SF Cold Chain provide temperature-controlled pharmaceutical logistics primarily in Asia-Pacific, with growing global ambitions. Comparable business model (GDP-compliant cold chain pharma transport) but different geographic focus than Eurotranspharma's European base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/eurotranspharma
• Facebookfacebook.com/eurotranspharma
• Instagraminstagram.com/eurotranspharma

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurotranspharma